SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples
Drug Delivery Devices

PUBLISHER: Grand View Research | PRODUCT CODE: 2151929

Cover Image

PUBLISHER: Grand View Research | PRODUCT CODE: 2151929

Automated Insulin Delivery Systems Market Size, Share & Trends Analysis Report By Product (Predictive Low Glucose Suspend System, Fully Closed Loop System), By Diabetes Type, By Age Group, By End-use, By Region, And Segment Forecasts, 2026 - 2033

PUBLISHED:
PAGES: 120 Pages
DELIVERY TIME: 2-10 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
Unprintable PDF & Excel (Single User License)
USD 5950
Printable PDF & Excel (5-User License)
USD 6950
Printable PDF & Excel (Enterprise License)
USD 8950

Add to Cart

Description

Table of Contents

List of Tables

Automated Insulin Delivery Systems Market Summary

The global automated insulin delivery systems market size was valued at USD 5.7 billion in 2025 and is projected to grow from USD 6.5 billion in 2026 to USD 18.8 billion by 2033, at a CAGR of 16.3% from 2026 to 2033. North America dominated the market, accounting for the largest revenue share of 40.7% in 2025. The automated insulin delivery (AID) systems combine an insulin pump, continuous glucose monitoring (CGM), and a software algorithm that uses glucose information to automatically adjust insulin delivery. The growing diabetes burden is creating a large underlying need for effective insulin-management solutions.

The International Diabetes Federation estimates that 589 million adults aged 20-79 years were living with diabetes globally in 2024, with the number projected to rise substantially over the coming decades. This expanding patient population, particularly people requiring intensive insulin therapy, provides a growing base of potential users for advanced insulin-delivery technologies.

A major factor supporting market growth is the increasing adoption of CGM and integrated diabetes technologies. CGM provides the continuous glucose information required for AID algorithms to automatically adjust insulin delivery, making CGM integration an important foundation for AID adoption. The American Diabetes Association's 2026 Standards of Care recommends CGM for people with diabetes using insulin and recognizes AID systems as a major component of modern diabetes technology. The guideline describes AID systems as technologies that use CGM-informed algorithms to modulate insulin delivery, demonstrating the increasing role of integrated pump-CGM systems in routine diabetes management. As CGM becomes more widely adopted and device interoperability improves, patients and healthcare professionals have greater access to integrated solutions capable of providing automated insulin adjustments.

Growing clinical evidence and expanding use of AID beyond type 1 diabetes are also strengthening market demand. Historically, AID systems were primarily associated with type 1 diabetes, but recent clinical studies have demonstrated benefits among insulin-treated people with type 2 diabetes. In a 2025 randomized clinical trial published in the New England Journal of Medicine, adults with insulin-treated type 2 diabetes who received AID experienced a greater reduction in HbA1c than those continuing their previous insulin-delivery method while using CGM. Another 2025 clinical study involving 305 adults with type 2 diabetes reported a reduction in average HbA1c from 8.2% to 7.4% after 13 weeks of AID use. These findings support the expansion of AID technology into a substantially broader insulin-treated population and strengthen the clinical rationale for adoption.

Global Automated Insulin Delivery Systems Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global automated insulin delivery systems market report based on product, diabetes type, age group, end-use, and region:

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Predictive Low Glucose Suspend (PLGS) System
  • Fully Closed Loop (FCL) System
  • Advanced Hybrid Closed Loop (AHCL) System
  • Diabetes Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Age Group Outlook (Revenue, USD Million, 2021 - 2033)
  • Pediatric
  • Adult & Geriatric
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals and Clinics
  • Homecare Settings
  • Others
  • Region Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Norway
    • Denmark
    • Sweden
  • Asia Pacific
    • China
    • Japan
    • South Korea
    • Thailand
    • Australia
    • India
  • Latin America
    • Brazil
    • Argentina
  • MEA
    • South Africa
    • Saudi Arabia
    • UAE
    • Kuwait
Show more
Product Code: GVR-4-68041-041-1

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Diabetes Type
    • 1.2.3. Age Group
    • 1.2.4. End Use
    • 1.2.5. Regional scope
    • 1.2.6. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Diabetes Type outlook
    • 2.2.3. Age Group outlook
    • 2.2.4. End Use outlook
    • 2.2.5. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Automated Insulin Delivery Systems Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Automated Insulin Delivery Systems Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Bargaining power of suppliers
      • 3.3.1.2. Bargaining power of buyers
      • 3.3.1.3. Threat of substitutes
      • 3.3.1.4. Threat of new entrants
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Automated Insulin Delivery Systems Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Automated Insulin Delivery Systems Market: Product Movement Analysis
  • 4.3. Automated Insulin Delivery Systems Market by Product Outlook (USD Million)
  • 4.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 4.5. Predictive Low Glucose Suspend (PLGS) System
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Fully Closed Loop (FCL) System
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Advanced Hybrid Closed Loop (AHCL) System
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Automated Insulin Delivery Systems Market: Diabetes Type Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Automated Insulin Delivery Systems Market: Diabetes Type Movement Analysis
  • 5.3. Automated Insulin Delivery Systems Market by Diabetes Type Outlook (USD Million)
  • 5.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 5.5. Type 1 Diabetes
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Type 2 Diabetes
    • 5.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Automated Insulin Delivery Systems Market: Age Group Estimates & Trend Analysis

  • 6.1. Segment Dashboard
  • 6.2. Automated Insulin Delivery Systems Market: Age Group Movement Analysis
  • 6.3. Automated Insulin Delivery Systems Market by Age Group Outlook (USD Million)
  • 6.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 6.5. Pediatric
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Adult & Geriatric
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Automated Insulin Delivery Systems Market: End Use Estimates & Trend Analysis

  • 7.1. Segment Dashboard
  • 7.2. Automated Insulin Delivery Systems Market: End Use Movement Analysis
  • 7.3. Automated Insulin Delivery Systems Market by End Use Outlook (USD Million)
  • 7.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 7.5. Hospitals and Clinics
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. Homecare Settings
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Others
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Automated Insulin Delivery Systems Market: Regional Estimates & Trend Analysis

  • 8.1. Regional Dashboard
  • 8.2. Regional Automated Insulin Delivery Systems Market Movement Analysis
  • 8.3. Automated Insulin Delivery Systems Market: Regional Estimates & Trend Analysis by Product & Diabetes Type
  • 8.4. Market Size & Forecasts and Trend Analyses, 2021 to 2033 for the following
  • 8.5. North America
    • 8.5.1. North America Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.2. U.S.
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Competitive Scenario
      • 8.5.2.3. Regulatory Framework
      • 8.5.2.4. Reimbursement scenario
      • 8.5.2.5. U.S. Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.3. Canada
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Competitive Scenario
      • 8.5.3.3. Regulatory Framework
      • 8.5.3.4. Reimbursement scenario
      • 8.5.3.5. Canada Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.4. Mexico
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Competitive Scenario
      • 8.5.4.3. Regulatory Framework
      • 8.5.4.4. Reimbursement scenario
      • 8.5.4.5. Mexico Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.5. Europe
    • 8.5.6. Europe Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.7. UK
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Competitive Scenario
      • 8.5.7.3. Regulatory Framework
      • 8.5.7.4. Reimbursement scenario
      • 8.5.7.5. UK Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.8. Germany
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Competitive Scenario
      • 8.5.8.3. Regulatory Framework
      • 8.5.8.4. Reimbursement scenario
      • 8.5.8.5. Germany Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.9. France
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Competitive Scenario
      • 8.5.9.3. Regulatory Framework
      • 8.5.9.4. Reimbursement scenario
      • 8.5.9.5. France Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.10. Italy
      • 8.5.10.1. Key Country Dynamics
      • 8.5.10.2. Competitive Scenario
      • 8.5.10.3. Regulatory Framework
      • 8.5.10.4. Reimbursement scenario
      • 8.5.10.5. Italy Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.11. Spain
      • 8.5.11.1. Key Country Dynamics
      • 8.5.11.2. Competitive Scenario
      • 8.5.11.3. Regulatory Framework
      • 8.5.11.4. Reimbursement scenario
      • 8.5.11.5. Spain Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.12. Denmark
      • 8.5.12.1. Key Country Dynamics
      • 8.5.12.2. Competitive Scenario
      • 8.5.12.3. Regulatory Framework
      • 8.5.12.4. Reimbursement scenario
      • 8.5.12.5. Denmark Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.13. Sweden
      • 8.5.13.1. Key Country Dynamics
      • 8.5.13.2. Competitive Scenario
      • 8.5.13.3. Regulatory Framework
      • 8.5.13.4. Reimbursement scenario
      • 8.5.13.5. Sweden Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.5.14. Norway
      • 8.5.14.1. Key Country Dynamics
      • 8.5.14.2. Competitive Scenario
      • 8.5.14.3. Regulatory Framework
      • 8.5.14.4. Reimbursement scenario
      • 8.5.14.5. Norway Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Competitive Scenario
      • 8.6.2.3. Regulatory Framework
      • 8.6.2.4. Reimbursement scenario
      • 8.6.2.5. Japan Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Competitive Scenario
      • 8.6.3.3. Regulatory Framework
      • 8.6.3.4. Reimbursement scenario
      • 8.6.3.5. China Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Competitive Scenario
      • 8.6.4.3. Regulatory Framework
      • 8.6.4.4. Reimbursement scenario
      • 8.6.4.5. India Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Competitive Scenario
      • 8.6.5.3. Regulatory Framework
      • 8.6.5.4. Reimbursement scenario
      • 8.6.5.5. South Korea Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Competitive Scenario
      • 8.6.6.3. Regulatory Framework
      • 8.6.6.4. Reimbursement scenario
      • 8.6.6.5. Australia Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Competitive Scenario
      • 8.6.7.3. Regulatory Framework
      • 8.6.7.4. Reimbursement scenario
      • 8.6.7.5. Thailand Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Competitive Scenario
      • 8.7.2.3. Regulatory Framework
      • 8.7.2.4. Reimbursement scenario
      • 8.7.2.5. Brazil Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Competitive Scenario
      • 8.7.3.3. Regulatory Framework
      • 8.7.3.4. Reimbursement scenario
      • 8.7.3.5. Argentina Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 8.8. Middle East & Africa
    • 8.8.1. Middle East & Africa Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Competitive Scenario
      • 8.8.2.3. Regulatory Framework
      • 8.8.2.4. Reimbursement scenario
      • 8.8.2.5. South Africa Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Competitive Scenario
      • 8.8.3.3. Regulatory Framework
      • 8.8.3.4. Reimbursement scenario
      • 8.8.3.5. Saudi Arabia Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Competitive Scenario
      • 8.8.4.3. Regulatory Framework
      • 8.8.4.4. Reimbursement scenario
      • 8.8.4.5. UAE Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Competitive Scenario
      • 8.8.5.3. Regulatory Framework
      • 8.8.5.4. Reimbursement scenario
      • 8.8.5.5. Kuwait Automated Insulin Delivery Systems Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Market Participant Categorization
  • 9.2. Key Company Profiles
    • 9.2.1. Medtronic plc
      • 9.2.1.1. Company Overview
      • 9.2.1.2. Financial Performance
      • 9.2.1.3. Product Benchmarking
      • 9.2.1.4. Strategic Initiatives
    • 9.2.2. Tandem Diabetes Care
      • 9.2.2.1. Company Overview
      • 9.2.2.2. Financial Performance
      • 9.2.2.3. Product Benchmarking
      • 9.2.2.4. Strategic Initiatives
    • 9.2.3. Insulet Corporation
      • 9.2.3.1. Company Overview
      • 9.2.3.2. Financial Performance
      • 9.2.3.3. Product Benchmarking
      • 9.2.3.4. Strategic Initiatives
    • 9.2.4. Ypsomed
      • 9.2.4.1. Company Overview
      • 9.2.4.2. Financial Performance
      • 9.2.4.3. Product Benchmarking
      • 9.2.4.4. Strategic Initiatives
    • 9.2.5. Nikkiso Co., Ltd.
      • 9.2.5.1. Company Overview
      • 9.2.5.2. Financial Performance
      • 9.2.5.3. Product Benchmarking
      • 9.2.5.4. Strategic Initiatives
    • 9.2.6. Beta Bionics, Inc.
      • 9.2.6.1. Company Overview
      • 9.2.6.2. Financial Performance
      • 9.2.6.3. Product Benchmarking
      • 9.2.6.4. Strategic Initiatives
    • 9.2.7. Diabeloop
      • 9.2.7.1. Company Overview
      • 9.2.7.2. Financial Performance
      • 9.2.7.3. Product Benchmarking
      • 9.2.7.4. Strategic Initiatives
    • 9.2.8. Medtrum GmbH
      • 9.2.8.1. Company Overview
      • 9.2.8.2. Financial Performance
      • 9.2.8.3. Product Benchmarking
      • 9.2.8.4. Strategic Initiatives
    • 9.2.9. CamDiab
      • 9.2.9.1. Company Overview
      • 9.2.9.2. Financial Performance
      • 9.2.9.3. Product Benchmarking
      • 9.2.9.4. Strategic Initiatives
    • 9.2.10. Sequel Med Tech, LLC
      • 9.2.10.1. Company Overview
      • 9.2.10.2. Financial Performance
      • 9.2.10.3. Product Benchmarking
      • 9.2.10.4. Strategic Initiatives
Show more
Product Code: GVR-4-68041-041-1

List of Tables

  • Table 1. List of Secondary Sources
  • Table 2. List of Abbreviations
  • Table 3. Global Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 4. Global Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 5. Global Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 6. Global Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 7. North America Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 8. North America Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 9. North America Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 10. North America Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 11. North America Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 12. U.S. Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 13. U.S. Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 14. U.S. Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 15. U.S. Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 16. Canada Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 17. Canada Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 18. Canada Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 19. Canada Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 20. Mexico Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 21. Mexico Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 22. Mexico Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 23. Mexico Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 24. Europe Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 25. Europe Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 26. Europe Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 27. Europe Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 28. Europe Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 29. UK Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 30. UK Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 31. UK Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 32. UK Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 33. Germany Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 34. Germany Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 35. Germany Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 36. Germany Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 37. France Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 38. France Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 39. France Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 40. France Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 41. Italy Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 42. Italy Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 43. Italy Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 44. Italy Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 45. Spain Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 46. Spain Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 47. Spain Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 48. Spain Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 49. Norway Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 50. Norway Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 51. Norway Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 52. Norway Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 53. Denmark Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 54. Denmark Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 55. Denmark Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 56. Denmark Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 57. Sweden Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 58. Sweden Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 59. Sweden Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 60. Sweden Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 61. Asia Pacific Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 62. Asia Pacific Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 63. Asia Pacific Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 64. Asia Pacific Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 65. Asia Pacific Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 66. China Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 67. China Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 68. China Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 69. China Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 70. Japan Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 71. Japan Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 72. Japan Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 73. Japan Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 74. South Korea Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 75. South Korea Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 76. South Korea Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 77. South Korea Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 78. Thailand Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 79. Thailand Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 80. Thailand Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 81. Thailand Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 82. Australia Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 83. Australia Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 84. Australia Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 85. Australia Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 86. India Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 87. India Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 88. India Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 89. India Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 90. Latin America Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 91. Latin America Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 92. Latin America Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 93. Latin America Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 94. Latin America Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 95. Brazil Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 96. Brazil Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 97. Brazil Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 98. Brazil Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 99. Argentina Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 100. Argentina Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 101. Argentina Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 102. Argentina Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 103. MEA Automated Insulin Delivery Systems Market, by Country, 2021 - 2033 (USD Million)
  • Table 104. MEA Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 105. MEA Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 106. MEA Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 107. MEA Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 108. South Africa Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 109. South Africa Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 110. South Africa Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 111. South Africa Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 112. Saudi Arabia Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 113. Saudi Arabia Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 114. Saudi Arabia Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 115. Saudi Arabia Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 116. UAE Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 117. UAE Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 118. UAE Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 119. UAE Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)
  • Table 120. Kuwait Automated Insulin Delivery Systems Market, by Product, 2021 - 2033 (USD Million)
  • Table 121. Kuwait Automated Insulin Delivery Systems Market, by Diabetes Type, 2021 - 2033 (USD Million)
  • Table 122. Kuwait Automated Insulin Delivery Systems Market, by Age Group, 2021 - 2033 (USD Million)
  • Table 123. Kuwait Automated Insulin Delivery Systems Market, by End Use, 2021 - 2033 (USD Million)

List of Figures

  • Fig 1. Information procurement
  • Fig 2. Primary research pattern
  • Fig 3. Market research approaches
  • Fig 4. Value chain-based sizing & forecasting
  • Fig 5. Market formulation & validation
  • Fig 6. Automated insulin delivery systems market segmentation
  • Fig 7. Market driver analysis (Current & future impact)
  • Fig 8. Market restraint analysis (Current & future impact)
  • Fig 9. SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig 10. Porter's Five Forces Analysis
  • Fig 11. Automated insulin delivery systems market, product outlook key takeaways (USD Million)
  • Fig 12. Automated insulin delivery systems market: product movement analysis (USD Million), 2025 & 2033
  • Fig 13. Predictive low glucose suspend (PLGS) system market estimates and forecasts, 2021-2033
  • Fig 14. Fully closed loop (FCL) system market estimates and forecasts, 2021-2033
  • Fig 15. Advanced hybrid closed loop (AHCL) system market estimates and forecasts, 2021-2033
  • Fig 16. Automated insulin delivery systems market, diabetes type outlook key takeaways (USD Million)
  • Fig 17. Automated insulin delivery systems market: diabetes type movement analysis (USD Million), 2025 & 2033
  • Fig 18. Type 1 Diabetes market estimates and forecasts, 2021-2033
  • Fig 19. Type 2 Diabetes market estimates and forecasts, 2021-2033
  • Fig 20. Automated insulin delivery systems market, age group outlook key takeaways (USD Million)
  • Fig 21. Automated insulin delivery systems market: age group movement analysis (USD Million), 2025 & 2033
  • Fig 22. Pediatric market estimates and forecasts, 2021-2033
  • Fig 23. Adult & geriatric market estimates and forecasts, 2021-2033
  • Fig 24. Automated insulin delivery systems market, end use outlook key takeaways (USD Million)
  • Fig 25. Automated insulin delivery systems market: end use movement analysis (USD Million), 2025 & 2033
  • Fig 26. Hospitals and clinics market estimates and forecasts, 2021-2033
  • Fig 27. Homecare settings market estimates and forecasts, 2021-2033
  • Fig 28. Others market estimates and forecasts, 2021-2033
  • Fig 29. Automated insulin delivery systems market, regional key takeaways (USD Million)
  • Fig 30. Automated insulin delivery systems market regional outlook, 2025 & 2033, USD Million
  • Fig 31. North America automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 32. U.S. automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 33. Canada automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 34. Mexico automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 35. Europe automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 36. UK automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 37. Germany automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 38. France automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 39. Italy automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 40. Spain automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 41. Denmark automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 42. Sweden automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 43. Norway automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 44. Asia Paciifc automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 45. Japan automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 46. China automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 47. India automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 48. Australia automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 49. South Korea automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 50. Thailand automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 51. Latin America automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 52. Brazil automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 53. Argentina automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 54. Middle East & Africa automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 55. South Africa automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 56. Saudi Arabia automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 57. UAE automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 58. Kuwait automated insulin delivery systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig 59. List of key emerging company's/indication disruptors/innovators
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!